Concepedia

Takuya Hemmi

TH

Statistics

Publications

6

Citations

227

H-Index

6

Active since

2022

Affiliations

National Institute of Infectious Diseases(Current)

Tokyo University of Science

Kyoto University

National Influenza Center

Kyushu University

Takuya Hemmi is an author at National Institute of Infectious Diseases specializing in sars-cov-2 infection, vaccination, and immunology.

ORCID

Publications per year

2022–2024

6

Publications

6

Vaccination-infection interval determines cross-neutralization potency to SARS-CoV-2 Omicron after breakthrough infection by other variants

Shô Miyamoto, Takeshi Arashiro, Yu Adachi et al. · Med · 2022 · 78 citations · Full text

, , +11

A lethal mouse model for evaluating vaccine-associated enhanced respiratory disease during SARS-CoV-2 infection

Naoko Iwata‐Yoshikawa, Nozomi Shiwa, Tsuyoshi Sekizuka et al. · Science Advances · 2022 · 60 citations · Full text

, , +17

Vaccination-infection interval determines cross-neutralization potency to SARS-CoV-2 Omicron after breakthrough infection by other variants

Shô Miyamoto, Takeshi Arashiro, Yu Adachi et al. · medRxiv · 2022 · 27 citations · Full text

, , +11

Structural basis for receptor-binding domain mobility of the spike in SARS-CoV-2 BA.2.86 and JN.1

Hisano Yajima, Yuki Anraku, Yu Kaku et al. · Nature Communications · 2024 · 24 citations · Full text

, , +17

Intranasal vaccination induced cross-protective secretory IgA antibodies against SARS-CoV-2 variants with reducing the potential risk of lung eosinophilic immunopathology

Takuya Hemmi, Akira Ainai, Takao Hashiguchi et al. · Vaccine · 2022 · 22 citations · Full text

, , +16

1–5 of 6